🔎 Trials Near Me

Почетна › Леукемија › Kalifornija

Kliničke studije za Леукемија u državi Kalifornija

30 studija za Леукемија traži učesnike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Zvanični tekst studije (na engleskom)

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • University of California, Fresno, Clovis
  • University of California, San Diego, La Jolla
  • Cedars-Sinai Medical Center, Los Angeles
  • и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

  • Children s Hospital of Los Angeles, Los Angeles
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 5 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT05237986

A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

  • City of Hope Center Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07751991

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 40 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05366881

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • City of Hope Comprehensive Cancer Center, Duarte
  • University of California, Irvine, Irvine
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • и још 2
Тражи се учесникФаза 3
Узраст од 18 до 71 · Оба пола · Ажурирано 30. 10. 2026. · NCT07504458

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  • San Francisco VA Medical Center, San Francisco, CA, San Francisco
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 30. 10. 2026. · NCT06520098

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • City of Hope, Duarte
  • Valkyrie Clinical Trials, Los Angeles
Тражи се учесникФаза 1/2
Узраст од 13 до 90 · Оба пола · Ажурирано 26. 10. 2026. · NCT06533579

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • Kaiser Permanente Downey Medical Center, Downey
  • City of Hope Comprehensive Cancer Center, Duarte
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • и још 10
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 20. 10. 2026. · NCT00736749

A Study of Revumenib and Mezigdomide in People With Leukemia

  • City of Hope Cancer Center (Data collection only), Duarte
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07356154

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Palo Alto
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06137118

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Keck School of Medicine of USC, Los Angeles
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04256317

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

  • Research Site, La Jolla
Тражи се учесникФаза 3
Узраст од 18 до 18 · Оба пола · Ажурирано 6. 10. 2026. · NCT07509151

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

  • USC Norris Comprehensive Cancer Center, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT06824168

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCLA Medical Center, Los Angeles
  • Stanford Cancer Institute, Stanford
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT04996875

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

  • Stanford University, Palo Alto
Тражи се учесникФаза 1
Узраст од 1 до 25 · Оба пола · Ажурирано 1. 9. 2026. · NCT06408194

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

  • Lucille Packard Children's Hospital of Stanford University, Palo Alto
Тражи се учесникФаза 1
18 Months – 39 Years · Оба пола · Ажурирано 21. 8. 2026. · NCT07573111

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • USC Norris Comprehensive Cancer Center, Los Angeles
  • UCLA Health - Bowyer Oncology Center, Los Angeles
  • UC Irvine Health Chao Family Comprehensive Cancer Center, Orange
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT06001788

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital Orange County, Orange
  • UCSF School of Medicine, San Francisco
Тражи се учесникФаза 2
Узраст од 7 до 25 · Оба пола · Ажурирано 19. 8. 2026. · NCT05082519

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

  • Stanford University, Palo Alto
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 8. 2026. · NCT06340737

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

  • David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 17. 7. 2026. · NCT06810778

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 14. 7. 2026. · NCT06580002

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • UCLA Department of Medicine, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

  • Dren Investigational Site, Duarte
  • Dren Investigational Site, Irvine
  • Dren Investigational Site, Redwood City
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 17. 6. 2026. · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • City of Hope Comprehensive Cancer Center, Duarte
  • Kaiser Permanente-Oakland, Oakland
  • Lucile Packard Children's Hospital Stanford University, Palo Alto
  • и још 1
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 18. 5. 2026. · NCT01790152

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • City of Hope, Duarte
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
  • и још 1
Тражи се учесникФаза 1/2
Узраст од 12 до 95 · Оба пола · Ажурирано 15. 4. 2026. · NCT04329728

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

  • Moores UC San Diego Cancer Center, La Jolla
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • UCLA - Bowyer Oncology Center, Los Angeles
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 13. 3. 2026. · NCT05735184

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • City of Hope - Duarte, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 31. 10. 2025. · NCT06549790

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duarte
  • Massive Bio SYNERGY-AI site, Irvine
  • Massive Bio SYNERGY-AI site, La Jolla
  • и још 3
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

  • City of Hope Medical Center, Duarte
  • University of California Los Angeles, Los Angeles
  • Stanford Cancer Center, Palo Alto
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2025. · NCT06501196

Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.

  • Children's Hospital Los Angeles, Los Angeles
Тражи се учесникЗдраве особе су добродошле
Узраст 3 и старији · Оба пола · Ажурирано 3. 8. 2025. · NCT06360718

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.